Surgalign Holdings, Inc., a global pure-play spine company focused on advancing the science of spine care by delivering innovative solutions, announced the pricing of an underwritten public offering of 25,000,000 shares of its common stock at a price to the public of $1.50 per share, before underwriting discounts and commissions.
January 27, 2021
· 4 min read